The impact of the Coronavirus (COVID-19) outbreak continues to disrupt our society as we know it, for many becoming a matter of life or death. While there is ongoing research & development work to identify solutions to address the pandemic, managed or expanded access to medicines is now more critical than ever to help address some of the urgent patient needs at various COVID-19 epicenters.
Paul Aliu, Global Head of Medical Governance, Chief Medical Office at Novartis, will share how Novartis was able to quickly mobilize their managed access program to effectively respond to the COVID-19 crisis, managing high volumes of both individual patient, institutional and government requests. Along with Zach Gendron, expert on managed/expanded access program technology, Paul will examine the key components, methods, strategies and the impact of managed/expanded access during this global pandemic.
